Adherence to Cognitive Behavioral Therapy for Insomnia (CBTI) Among Women Following Primary Breast Cancer Treatment: A Pilot Study

Ellyn E. Matthews; Sarah J. Schmiege; Paul F. Cook; Ann M. Berger; Mark S. Aloia

doi:10.1080/15402002.2012.666220

Adherence to Cognitive Behavioral Therapy for Insomnia (CBTI) Among Women Following Primary Breast Cancer Treatment: A Pilot Study

Ellyn E. Matthews, Sarah J. Schmiege, Paul F. Cook, Ann M. Berger, Mark S. Aloia

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Abstract

Cognitive behavioral therapy for insomnia (CBTI) has proven efficacy, yet 32%-89% of patients fail to consistently follow recommendations. This pilot study examines adherence to CBTI in breast cancer survivors with insomnia. There was a significant decline in adherence to prescribed rise time, and total time in bed, but no change in adherence to prescribed bedtime during six weekly sessions. Factors associated with higher adherence included lower fatigue and higher baseline motivation. Higher adherence was associated with worse subjective sleep quality at the beginning of CBTI and fewer nocturnal awakenings at the end of treatment. Results provide preliminary evidence supporting the impact of adherence on sleep outcomes such as fewer nocturnal awakenings. Attention to adherence as part of CBTI may yield greater sleep improvements.

Original language	English (US)
Pages (from-to)	217-229
Number of pages	13
Journal	Behavioral Sleep Medicine
Volume	10
Issue number	3
DOIs	https://doi.org/10.1080/15402002.2012.666220
State	Published - Jun 2012

ASJC Scopus subject areas

Neuroscience (miscellaneous)
Medicine (miscellaneous)
Psychology (miscellaneous)
Clinical Neurology

Access to Document

10.1080/15402002.2012.666220

Cite this

@article{04a080d2dbd94b25b81053b334a33739,

title = "Adherence to Cognitive Behavioral Therapy for Insomnia (CBTI) Among Women Following Primary Breast Cancer Treatment: A Pilot Study",

abstract = "Cognitive behavioral therapy for insomnia (CBTI) has proven efficacy, yet 32%-89% of patients fail to consistently follow recommendations. This pilot study examines adherence to CBTI in breast cancer survivors with insomnia. There was a significant decline in adherence to prescribed rise time, and total time in bed, but no change in adherence to prescribed bedtime during six weekly sessions. Factors associated with higher adherence included lower fatigue and higher baseline motivation. Higher adherence was associated with worse subjective sleep quality at the beginning of CBTI and fewer nocturnal awakenings at the end of treatment. Results provide preliminary evidence supporting the impact of adherence on sleep outcomes such as fewer nocturnal awakenings. Attention to adherence as part of CBTI may yield greater sleep improvements.",

author = "Matthews, {Ellyn E.} and Schmiege, {Sarah J.} and Cook, {Paul F.} and Berger, {Ann M.} and Aloia, {Mark S.}",

note = "Funding Information: This study was funded by the National Institute of Health and Research (1K23NR010587).",

year = "2012",

month = jun,

doi = "10.1080/15402002.2012.666220",

language = "English (US)",

volume = "10",

pages = "217--229",

journal = "Behavioral Sleep Medicine",

issn = "1540-2002",

publisher = "Routledge",

number = "3",

}

TY - JOUR

T1 - Adherence to Cognitive Behavioral Therapy for Insomnia (CBTI) Among Women Following Primary Breast Cancer Treatment

T2 - A Pilot Study

AU - Matthews, Ellyn E.

AU - Schmiege, Sarah J.

AU - Cook, Paul F.

AU - Berger, Ann M.

AU - Aloia, Mark S.

N1 - Funding Information: This study was funded by the National Institute of Health and Research (1K23NR010587).

PY - 2012/6

Y1 - 2012/6

N2 - Cognitive behavioral therapy for insomnia (CBTI) has proven efficacy, yet 32%-89% of patients fail to consistently follow recommendations. This pilot study examines adherence to CBTI in breast cancer survivors with insomnia. There was a significant decline in adherence to prescribed rise time, and total time in bed, but no change in adherence to prescribed bedtime during six weekly sessions. Factors associated with higher adherence included lower fatigue and higher baseline motivation. Higher adherence was associated with worse subjective sleep quality at the beginning of CBTI and fewer nocturnal awakenings at the end of treatment. Results provide preliminary evidence supporting the impact of adherence on sleep outcomes such as fewer nocturnal awakenings. Attention to adherence as part of CBTI may yield greater sleep improvements.

AB - Cognitive behavioral therapy for insomnia (CBTI) has proven efficacy, yet 32%-89% of patients fail to consistently follow recommendations. This pilot study examines adherence to CBTI in breast cancer survivors with insomnia. There was a significant decline in adherence to prescribed rise time, and total time in bed, but no change in adherence to prescribed bedtime during six weekly sessions. Factors associated with higher adherence included lower fatigue and higher baseline motivation. Higher adherence was associated with worse subjective sleep quality at the beginning of CBTI and fewer nocturnal awakenings at the end of treatment. Results provide preliminary evidence supporting the impact of adherence on sleep outcomes such as fewer nocturnal awakenings. Attention to adherence as part of CBTI may yield greater sleep improvements.

UR - http://www.scopus.com/inward/record.url?scp=84863514156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863514156&partnerID=8YFLogxK

U2 - 10.1080/15402002.2012.666220

DO - 10.1080/15402002.2012.666220

M3 - Article

C2 - 22742439

AN - SCOPUS:84863514156

SN - 1540-2002

VL - 10

SP - 217

EP - 229

JO - Behavioral Sleep Medicine

JF - Behavioral Sleep Medicine

IS - 3

ER -

Adherence to Cognitive Behavioral Therapy for Insomnia (CBTI) Among Women Following Primary Breast Cancer Treatment: A Pilot Study

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this